An FDA panel supports Merck COVID drug in mixed vote

If the Food and Drug Administration authorizes use of the drug, called molnupiravir, it would be the first oral COVID-19 treatment that could be taken at home.

Related Keywords

Lindsey Baden ,Nicholas Kartsonis ,Ridgeback Biotherapeutics ,John Coffin ,Janet Cragan ,Centers For Disease ,Pfizer ,Drug Administration ,Tufts University ,Disease Control ,